In person event Venues 133 Houndsditch in London.
Go West! – Considerations For US IPOs And Dual Listings
Moderator: Isabella Schidrich, Senior Managing Director, Nasdaq
Pierluigi Paracchi, CEO & Co-founder, Genenta Science
Steve Hurly, CEO, Lava Therapeutics
Piers Morgan, CFO, Cellcentric
Fredrik Johansson, CFO, Calliditas Therapeutics
LCA – in collaboration with Goodwin – will host the webinar “The NASDAQ IPO Path for Italian Life Science Companies: Genenta Science’s Case Study”, Speaker: Ettore Santucci (Goodwin), Pierluigi Paracchi (Genenta), Aparna Beeram (Roth Capital Partners), Federica Draghi (Genextra) and Leonardo Vingiani (Federchimica), together with Andrea Messuti (LCA)
Co-hosted by Nobel laureate and Biogen/Alnylam co-founder Phil Sharp.
Stewart Geary, CMO, Eisai
Francesco Hofmann, Head, R&D, Pierre Fabre
Cristin Hubbard, Head, Global Partnering, Diagnostics, Roche
Ryan Richardson, Chief Strategy Officer, BioNTech
Carlo Russo, CMO, Genenta Science
Moderator: Stuart Mackey, Global Head, BD, Daiichi Sankyo
Hosted by Genenta Science
Moderated by Brad Loncar
In this fireside chat, Genenta is delighted to bring together renowned neuro-oncologist David Reardon, MD (Harvard Medical School, Dana-Farber Cancer Institute) and Professor Luigi Naldini, MD, PhD (San Raffaele Telethon Institute for Gene Therapy), considered by many as the “father” of lentiviral gene therapy to discuss the potential application of immuno gene & cell therapy as a potential treatment for glioblastoma and other solid tumors. Genenta's Temferon™, a lentivirus based hematopoietic stem progenitor cell immuno gene & cell therapy enabling controlled and targeted interferon-α expression within cancers, will be discussed as a potential treatment solution for glioblastoma patients.
Brad Loncar (CEO of Loncar Investments) will serve as the fireside chat moderator and Carlo Russo, MD (Genenta CMO & Head of Development) will also participate in the discussion.
A live question and answer session will follow.
Speaker: Stefania Mazzolone Ph.D Scientifica Project Manager and Communication Officier
The workshop will be held both in presence (by invitation only) and online In person event at MIND – Milan Innovation District
Speaker Carlo Russo, Chief Medical Officer & Head of Development Genenta Science
Speaker Pierluigi Paracchi, CEO & Co-Founder Genenta Science